Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
172.5 USD | +5.60% | +2.84% | -4.07% |
02/05 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
01/05 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.07% | 912.68Cr | |
-5.51% | 18TCr | |
+2.33% | 11TCr | |
-3.62% | 6.85TCr | |
+1.52% | 4.97TCr | |
+8.06% | 4.45TCr | |
+3.01% | 4.07TCr | |
+23.35% | 3.12TCr | |
+0.67% | 2.61TCr | |
+19.13% | 2.53TCr |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- UBS Adjusts Repligen Price Target to $210 From $199, Maintains Buy Rating